PRELIMINARY RESULTS OF A PHASE II RANDOMIZED STUDY (ROMULUS) OF POLATUZUMAB VEDOTIN OR PINATUZUMAB VEDOTIN PLUS RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (NHL) Morschhauser, F., Flinn, I., Advani, R., Sehn, L., Kolibaba, K., Press, O., Salles, G., Diefenbach, C., Tilly, H., Assouline, S., Chen, A., Dreyling, M., Hagenbeek, A., Zinzani, P. L., Cheson, B. D., Yalamanchili, S., Lu, D., Chai, A., Chu, Y. W., Sharman, J. FERRATA STORTI FOUNDATION. 2014: 525

View details for Web of Science ID 000342830902333